Private company

Akoya Biosciences, Inc.

Last updated Oct 16, 2026.

Overview

  • IndustryLaboratory Analytical Instruments
  • HeadquartersDE
  • Incorporated inDE2
  • Business address100 Campus Drive, 6Th Floor, Marlborough, Ma 017622
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

58.6%Gross margin3
-57.2%Operating margin3
-67.8%Net margin3
-15.5%Revenue growth, 20243
-729.0%Return on equity3
10.03×Debt to equity3
-$46.6MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue27¢$33.8M
  • Research and development16¢$19.7M
  • Selling, general and admin56¢$69.3M
  • Income tax0¢$146.0K

Out of $81.7M in revenue.3 The company lost money this year.

Financial statements

Revenue4563$81.7M in 2024+92% since 2020
0$25.0M$50.0M$75.0M$100.0M2020: $42.4M$42.4M20202021: $54.9M$54.9M2021+29%2022: $74.9M$74.9M2022+36%2023: $96.6M$96.6M2023+29%2024: $81.7M$81.7M2024−15%
Gross profit4563$47.9M in 2024+85% since 2020
0$20.0M$40.0M$60.0M2020: $25.9M$25.9M20202021: $34.2M$34.2M2021+32%2022: $43.4M$43.4M2022+27%2023: $56.3M$56.3M2023+30%2024: $47.9M$47.9M2024−15%
Operating income4563-$46.7M in 2024+289% since 2020
-$80.0M-$60.0M-$40.0M-$20.0M02020: -$12.0M-$12.0M20202021: -$39.3M-$39.3M2021+227%2022: -$66.1M-$66.1M2022+68%2023: -$57.7M-$57.7M2023−13%2024: -$46.7M-$46.7M2024−19%
Net income4563-$55.4M in 2024+231% since 2020
-$80.0M-$60.0M-$40.0M-$20.0M02020: -$16.7M-$16.7M20202021: -$42.9M-$42.9M2021+157%2022: -$70.6M-$70.6M2022+65%2023: -$63.3M-$63.3M2023−10%2024: -$55.4M-$55.4M2024−13%
Fiscal year201920202021202220232024
Revenue$42.4M4$54.9M5$74.9M6$96.6M3$81.7M3
Cost of revenue$16.5M4$20.7M5$31.5M6$40.3M3$33.8M3
Gross profit$25.9M4$34.2M5$43.4M6$56.3M3$47.9M3
Research and development$9.6M4$15.7M5$23.2M6$25.0M3$19.7M3
Selling, general and admin$24.0M4$51.0M5$79.7M6$87.4M3$69.3M3
Operating income-$12.0M4-$39.3M5-$66.1M6-$57.7M3-$46.7M3
Income tax$42.0K4-$140.0K5$123.0K6$40.0K3$146.0K3
Net income-$16.7M4-$42.9M5-$70.6M6-$63.3M3-$55.4M3
Earnings per share-$9.184-$1.655-$1.876-$1.433-$1.123
Earnings per share (diluted)-$9.184-$1.655-$1.876-$1.433-$1.123

Compare Akoya Biosciences, Inc. with another company

Recent filings

  1. Jul 10, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  2. Jul 10, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  3. Jul 10, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  4. Jul 10, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  5. Jul 10, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  6. Jul 10, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  7. Jul 10, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  8. Jul 10, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  9. Jul 10, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  10. Jul 10, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  11. Jul 10, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  12. Jul 8, 20258-K
  13. Jul 7, 20258-K
  14. Jun 2, 20258-K
  15. Jun 2, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9